Subscribe to email alerts

MediPharm Labs 26/07/2019

MediPharm Labs Announces Trading Date on the Toronto Stock Exchange

MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, distillation, purification and cannabinoid isolation, is pleased to announce that its common shares are expected to begin trading on the Toronto Stock Exchange (“TSX”) on Monday, July 29, 2019 under the symbol “LABS”. At that time, MediPharm Labs’ common shares will be voluntarily delisted from the TSX Venture Exchange.

A market open ceremony with MediPharm Labs will be announced.


Founded in 2015, MediPharm Labs specializes in the production of purified, pharmaceutical-grade cannabis oil and concentrates and advanced derivative products utilizing cGMP (current Good Manufacturing Practices) designed facility and ISO standard built clean rooms. MediPharm Labs has invested in an expert, research-driven team, state-of-the-art technology, downstream purification methodologies and purpose-built facilities with 5 primary extraction lines having 300,000 KG of annual processing capacity to deliver pure, safe and precisely-dosed cannabis products for its customers. Through the Company’s wholesale, private and white label platform, MediPharm Labs formulates, processes, packages and distributes active pharmaceutical ingredients and advanced cannabinoid-based products to domestic and international markets. As a global leader, MediPharm Labs’ completed its first commercial export to Australia in June 2019 and is nearing completion of its Australian extraction facility expected in 2019 with 75,000 KG of annual processing capacity.

Back to News

Related Articles

MediPharm Labs

MediPharm Labs Submits Application to List on NASDAQ

06/11/2019 Read more
MediPharm Labs

MediPharm Labs Increases Exports of Medical Cannabis Concentrate to Australia

02/10/2019 Read more
Fire & Flower

Fire & Flower Announces Strategic Investment by Alimentation Couche-Tard, Sets Sights on Global Cannabis Market and Conditional Approval to Uplist to the Toronto Stock Exchange

25/07/2019 Read more
MediPharm Labs

MediPharm Labs Australia Awarded Cannabis Manufacturing Licence

23/05/2019 Read more


Subscribe to email alerts